The past project periods dissected the biologic heterogeneity of Alzheimer's disease (AD) and found that it is a chronic disease with a preclinical, mild, and dementia phase. We found that co-morbid pathologies contribute to the AD phenotype. We identified many genomic, medical, experiential, and psychological factors associated with cognitive decline and incident AD dementia. Finally, we investigated the neurobiologic pathways linking risk factors to clinical and pathologic AD phenotypes. Interestingly, only genomic variants were associated with cognitive decline and AD dementia, and with AD pathology. Recent GWAS studies have nominated many genomic variants for AD dementia. The overall goal of the proposed continuation is to identify brain proteins and proteoforms linking AD risk genes to AD endophenotypes, i.e., AD pathology and cognitive decline. The proposed study will build on results of recent GWAS by leveraging multi-layered genomic data and post-mortem biospecimens from two ongoing cohort studies of aging and dementia.
Aim 1 will sequence and do fine mapping of known AD risk genes to identify sequence variants and haplotypes associated with AD endophenotypes in a Discovery Cohort.
Aims two will conduct identical analyses in a Confirmatory Cohort and then conduct pooled analyses of both Cohorts to increase power.
Aim three will leverage available DNA methylation, H3K9 histone acetylation, miRNA, RNAseq, and public reference data to identify the molecular pathways linking genomic variants to transcripts and AD endophenotypes.
Aim 4 will use liquid chromatography mass spectrometry (LC-MS) proteomics techniques to measure protein and proteoform abundances, and to identify isoforms and post-translational modifications linking AD risk genes to AD endophenotypes. An exploratory aim will assess for pleitropy by exploring the relation of AD risk genes, transcripts, and proteins with other pathologic and clinical phenotypes, and AD risk factors. The proposed study represents the logical next step following the successful AD gene discovery efforts. It uses an innovative and timely approach to integrate genomic, epigenomic, and transcriptomic data from human brain, characterize the molecular events linking AD risk genes to AD endophenotypes. Then it identifies proteins, isoforms, and post-translational modifications linking AD risk genes with AD endophenotypes. These proteins and proteoforms will be high value therapeutic targets. The identification of these proteins will provide new directions for research and treatment and thereby have high and sustained impact in the field.

Public Health Relevance

Using an innovative and timely approach integrating genomic, epigenomic, and transcriptomic data from human brain, we will characterize the molecular events linking AD risk genes to AD phenotypes, and identify proteins, isoforms, and post-translational modifications linking AD risk genes to AD endophenotypes. The identification of these proteins will provide new directions for research and treatment and thereby have high and sustained impact in the field.

Agency
National Institute of Health (NIH)
Type
Multi-Year Funded Research Project Grant (RF1)
Project #
2RF1AG015819-16
Application #
8760760
Study Section
Neurological, Aging and Musculoskeletal Epidemiology Study Section (NAME)
Program Officer
Anderson, Dallas
Project Start
Project End
Budget Start
Budget End
Support Year
16
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Rush University Medical Center
Department
Neurosciences
Type
Schools of Medicine
DUNS #
City
Chicago
State
IL
Country
United States
Zip Code
60612
Dawe, Robert J; Yu, Lei; Leurgans, Sue E et al. (2016) Postmortem MRI: a novel window into the neurobiology of late life cognitive decline. Neurobiol Aging 45:169-77
Sivam, Anita; Wroblewski, Kristen E; Alkorta-Aranburu, Gorka et al. (2016) Olfactory Dysfunction in Older Adults is Associated with Feelings of Depression and Loneliness. Chem Senses 41:293-9
Wilson, Robert S; Capuano, Ana W; Marquez, David X et al. (2016) Change in Cognitive Abilities in Older Latinos. J Int Neuropsychol Soc 22:58-65
Sherman, Mathew A; LaCroix, Michael; Amar, Fatou et al. (2016) Soluble Conformers of Aβ and Tau Alter Selective Proteins Governing Axonal Transport. J Neurosci 36:9647-58
Hohman, Timothy J; Cooke-Bailey, Jessica N; Reitz, Christiane et al. (2016) Global and local ancestry in African-Americans: Implications for Alzheimer's disease risk. Alzheimers Dement 12:233-43
Buchman, Aron S; Wilson, R S; Shulman, Joshua M et al. (2016) Parkinsonism in Older Adults and Its Association With Adverse Health Outcomes and Neuropathology. J Gerontol A Biol Sci Med Sci 71:549-56
Hohman, Timothy J; Bush, William S; Jiang, Lan et al. (2016) Discovery of gene-gene interactions across multiple independent data sets of late onset Alzheimer disease from the Alzheimer Disease Genetics Consortium. Neurobiol Aging 38:141-50
Hinrich, Anthony J; Jodelka, Francine M; Chang, Jennifer L et al. (2016) Therapeutic correction of ApoER2 splicing in Alzheimer's disease mice using antisense oligonucleotides. EMBO Mol Med 8:328-45
Arvanitakis, Zoe; Capuano, Ana W; Leurgans, Sue E et al. (2016) The Relationship of Cerebral Vessel Pathology to Brain Microinfarcts. Brain Pathol :
Pruzin, Jeremy J; Schneider, Julie A; Capuano, Ana W et al. (2016) Diabetes, Hemoglobin A1C, and Regional Alzheimer Disease and Infarct Pathology. Alzheimer Dis Assoc Disord :

Showing the most recent 10 out of 106 publications